Background: Malaria accounts for 60% of outpatient visits in Nigeria. The aim of the study was to assess the knowledge of malaria and its treatment practices in Enugu state, Nigeria. Methods: Qualitative data was collected through the use of focus group discussions (FGDs), from six villages three each from urban and rural areas of Enugu state, Nigeria. A total of 18 FGDs involving 189 participants were conducted and data on place of treatment for malaria and drug of choice for malaria treatment were collected. Results: Most discussants had a good knowledge of the signs and symptoms of malaria. They reported late for treatment when they had symptoms suggestive of malaria. Treatment timing was affected by financial capability and perceived severity of disease. There was preference for patent medicine dealers (PMDs) and pharmacies for malaria treatment. The reasons included drug affordability, obtaining preferred drug, short waiting time and polite treatment from the providers. Treatment in most cases was without proper malaria diagnosis. Cost was an important factor in determining the drug of choice for malaria treatment. This could explain why people were not aware of the use of artemisininbased combination therapy while preferring mono-therapies and herbal drugs. Public hospitals were considered as good sources of treatment for malaria although they remain the last resort when treatment from these drug outlets failed.
Implications for policy makers •
The government and its health agencies should ensure an improvement in delivery of public healthcare services through evidence based health policy formulations and training of health workers.
•
On malaria management, emphasis should be placed on proper diagnosis of malaria and treatment using artemisinin-based combination therapy.
• Training of pharmacists and patent medicine dealers on malaria treatment so as to improve quality. • Increase public awareness on management of malaria.
Implications for the public
Community members have preference for patent medicine dealers (PMDs) and pharmacies for malaria treatment. Unfortunately, treatment prescribed in these outlets did not include the use of artemisinin-based combination therapy. This is irrespective of the fact that the Nigerian government adopted the World Health Organization (WHO) guidelines on artemisinin combination therapy (ACT) use for treatment of uncomplicated malaria in 2005. This policy however did not forbid the sale of mono-therapies in the country. There is thus a need to improve peoples' knowledge on the right actions to take when they have signs and symptoms suggestive of malaria and this will go a long way in improving the control of malaria. Efforts should be made to discourage the public from self-treatment of malaria.
Background
Nigeria bears more than a quarter of the global burden of malaria. 1 Nationally, 97% of the population are at risk of the disease. 2 The result is that malaria accounts for an estimated 60% of out-patient hospital visits, 30% of hospital admissions and 11% of maternal mortalities in the country. 3 Malaria also has a deteriorating effect on the economy as an estimated 132 billion Naira (700 million dollars) is lost due to treatment costs, prevention and other indirect costs. 4 To reduce the malaria burden, the World Health Organization (WHO) recommends use of artemisinin combination therapy (ACT), for uncomplicated malaria that is confirmed with either microscopy or rapid diagnostic test (RDT), in a bid to reduce the misuse of ACT. 5, 6 The Nigerian government adopted the WHO guidelines on the use of ACTs for the treatment of uncomplicated malaria in 2005. 7 Unavailability and inaccessibility of healthcare facilities especially in rural areas in Nigeria is a limitation to provision of appropriate and effective malaria treatment services. 8, 9 Malaria treatment is sought through different healthcare providers including government accredited health facilities and drug retail outlets like pharmacies and patent medicine dealers (PMDs). Studies have established that these drug retail outlets are usually ineffective in the management and treatment of malaria. [10] [11] [12] [13] PMDs refer to licensed retail outlets whose attendants are not trained pharmacists but can sell over the counter drugs such as analgesics and anti-malarials. 14 Pharmacies are also medicine retail outlets attended by trained pharmacists whose practice is governed by pharmacy law in Nigeria. 15 Most patients often prefer this informal sector due to their availability, accessibility and lower cost of treatment although treatment may be inappropriate and practice may be inconsistent with national treatment guidelines. 14, 16, 17 Increased utilization of the informal sectors in management and treatment of malaria has become a major public health problem. For instance, both seller and consumer may not have requisite knowledge of appropriate dosage and duration of treatment. In-order to improve malaria case management within communities, strategies such as health education to caregivers and training of community volunteers on management of malaria in children have been used. 18, 19 Health education has also been found to positively influence early diagnosis and appropriate treatment in home management of malaria by caregivers. 20 If understood, the current treatment seeking behaviour could be useful in informing design of strategies and programs on improving provision and utilization of appropriate malaria case management. The purpose of this study was to determine the knowledge of malaria and its treatment practices in urban and rural areas of Enugu state, Nigeria.
Methods

Study Area
The study was conducted in Enugu state in the southeast geo-political zone of Nigeria. It is made up of seventeen local government areas, five of which are urban while twelve are rural. (see Figure) . Inhabitants were mainly of Igbo ethnic nationality and predominantly profess the Christian faith. Their main livelihood activities were farming, fishing and wine tapping. Enugu state operates the district health system which is an administrative and management arrangement that merges primary and secondary healthcare. Healthcare services are mostly provided through primary health centres under the authority of the local government councils, secondary health facilities which are controlled by the government of Enugu state and tertiary hospitals which are owned by the federal government of Nigeria. There are also private health facilities, PMDs and pharmacies. Major sources of malaria treatment in the state include public and private health facilities, pharmacies and PMDs. The pharmacies and PMDs do not offer diagnostic or clinical care but are basically medicine retailers although they do recommend drugs to clients. Enugu state has a high malaria transmission rate all year round.
Sample Selection A multi-stage sampling method was used in the study. In the first stage, a simple random sampling technique was used to select one local government area from the urban and rural areas of the state. In the second stage, three villages were selected from each of the selected local government areas using simple random sampling technique. Participants were then purposively selected to represent three target groups in each of the villages selected for the study. All participants were aged 25 years or more and were categorized into three groups: women with children under 5 years; women without children; and men. They were drawn from the selected villages by contact persons who were carefully identified by the research team.
Study Design This was a cross-sectional qualitative study. Data was collected through focus group discussions (FGDs) with the three categories of discussants and the help of an FGD guide. A total of 18 FGDs were conducted, six with every discussant category. Of the six, three were with discussants from rural areas and the other half from urban areas. Each FGD had an average of 10 participants.
Study Participants
The study consisted of 189 participants who resided in the selected urban and rural areas of Enugu state, Nigeria. This included 63 male and 116 female participants. The participants must have lived in the selected villages for more than two years. This was considered adequate for them to have understood how the people in this area managed malaria.
Data Collection
During the FGDs data on malaria knowledge levels and treatment seeking practices were collected. Before data collection, the FGD guide was pretested in two different villages not selected for the study. This was to ensure that there were no ambiguities in the questions. The FGDs were conducted by the researchers in the local language (Igbo), and were conducted in secluded places like public primary schools and community town halls and lasted between 45 to 60 minutes each. All FGDs were recorded manually and using recorders.
Data Analysis
The recorded discussions were transcribed verbatim following each session by transcribers and then translated to English by two native speakers with good command of both languages. For quality assurance purposes, the scripts were compared with the written notes for completeness and accuracy. Further, each script was checked against the audiotape by an independent reviewer. In-order to verify the quality of translations, tapes were doubly transcribed after which both scripts were checked for similarity and where differences existed, these were reconciled by the transcribers. Coding of transcripts was done based on emergent themes. Five themes emerged from the study and included malaria signs and symptoms in adults and children, when to seek treatment for adults and children and where to seek treatment for adults and children. Others included communities' use of PMDs and pharmacies for treatment and medicines used for malaria treatment.
Limitations of the Study Use of FGD only could have affected the results of the study. For example, the non-random selection of discussants means that the study findings cannot be generalized to the entire Enugu state population. The researchers had no control over the participants selected by community contact persons despite having given them a selection criterion and thus there may have been a selection bias. Not eliciting the cause of malaria from the participants is a weakness on its own. Furthermore, data was collected only from community members with none from the operators of pharmacies and PMDs.
Results
Participants' Profile
The age range of study participants in the urban area was 26 to 42 years and a median age of 33. In rural areas, participants' age range was 28-49 years, with a median of 39. The majority of the participants had completed secondary education.
Malaria Signs and Symptoms in Adults and Children
Most study participants identified headache and fever as symptoms of malaria. Other symptoms correctly recognized by the participants included weakness, cold, body pains and dizziness as signs and symptoms of malaria. In fact, a participant particularly paid attention on fever as the main symptom of malaria. This was expressed this way:
" A participant who patronises PMDs prefers the use of injections based on his perceived severity of malaria. From his comments, it could be deduced that he indicates his choice of medicines. He said: "… for me, I go straight to 'ore ogwu' (meaning PMD) and demand for chloroquine injection which works very well for me or fansidar (a brand of sulphadoxine-pyremethamine) if I think that it is not a serious malaria" (Male discussant, urban area). Another male participant in the rural area supported this view by stating that generally injections work better and faster than tablets any time. A few of the participants relied more on prevention of malaria rather than its cure. Unfortunately, their understanding of preventive measures is questionable. One of the participants presented it this way:
"The best treatment is for everybody to be careful with the type of food and water that we take but the major one is the water that we drink and the environment where the person is living. All these could contribute to our being sick with malaria" (Female discussant, urban area). Some of the participants could not remember the names of the drugs they usually take for malaria treatment. These may be the people who present to the PMDs or pharmacies and rely on their expertise for treatment. They may also include those who present at private health facilities for treatment as they may make do with the doctor or any other health practitioner's choice of drugs since they perceive that they may be guided by the result of a laboratory test.
Discussion
From the results of this study, headache and fever were identified as the major symptoms of malaria. This is similar to the results of other studies in which fever was regarded as one of the main symptoms of malaria. 21, 22 Even though the community members had good knowledge of malaria symptoms, certain misconceptions still exist like the reliance on yellowish urine, bitterness of mouth which are very subjective as symptoms of malaria in adults and in children, the linking of catarrh to headache hence interpreted as a symptom of malaria. Elsewhere it has been found that the knowledge of severe symptoms of malaria among the participants was very poor, 21 and unlike the study among undergraduates in Nigeria, 21 no participant in this study mentioned coma, convulsion and anaemia which are complications of malaria as symptoms of malaria. Similarly, the comment on prevention of malaria in which the disease was linked with air and water is also misleading. It has been found that misconceptions on cause and transmission of malaria still exist among the people, 23 and this necessitates that studies of this nature should begin with eliciting the perceived cause of malaria from the participants. Also based on the observation that knowledge of cause of malaria affect health seeking behaviour, there has been a call for the enlightenment of the people on the transmission of malaria as this will influence health seeking behaviour. 24 Interestingly, a study in Malawi also identified the need to improve the knowledge of the symptoms of malaria among caregivers. 25 As such emphasizing the need to intensify malaria enlightenment programmes. 26 Most community members did not receive adequate malaria diagnosis. It has been found that in Africa most patients with fever, which could be suggestive of malaria, present at the informal sector where malaria diagnosis using RDT is not very common. 27, 28 However based on the acceptance of RDT by the drug outlets and members of the community, there is need to educate the public on the use of RDT at the community so as to improve malaria case detection. 28 Thus use of RDT in drug retail outlets has been advocated for, 27 and this is in line with one of the pillars of the WHO global strategy for malaria which is to ensure universal access to malaria prevention, diagnosis and treatment. 29 This approach includes the scaling up of community based diagnostic testing and treatment of malaria, 29 which could be achieved with the involvement of the drug retail outlets in management of malaria. The delay of two or three days in seeking for treatment for symptoms suggestive of malaria among the participants may be attributed to the effect of a popular advertorial for a well-known analgesic which was repeatedly aired on the electronic media and the message requested the populace to consult a physician after three days if symptoms persisted after the use of the analgesic. It is important to note that the advertisement was not for malaria treatment but may have been misunderstood by the people. At that period also, there was no emphasis on malaria diagnosis using RDT or microscopy before treatment. Since the people are consciously holding on to the values of that advice, there may be the need for increased public awareness on the current World Health Organization guidelines on the diagnosis and treatment of malaria. This is important in changing the perception of the people on use of analgesics thus encouraging the members of the public to make right choices for malaria treatment. This has necessitated the call for interventions that will improve the awareness of caregivers on the relevance of seeking medical care early and advocating for early diagnosis and treatment for malaria. This obviously will reduce the likelihood of complications of malaria. 30 Another hindrance to seeking treatment early by the participants may be related to cost. In Nigeria, out of pocket expenditure for health is the main source of financing for health and this is irrespective of the fact that majority of the populace live in abject poverty. 31 Undoubtedly, this has been identified as a barrier to accessing healthcare, 32 hence in a study that involved government employees in southeast Nigeria, who are more enlightened than the average population, those who relied on out of pocket expenditure had difficulties assessing quality healthcare services. 33 Perhaps, the introduction of alternative health financing mechanisms will help in ensuring universal access to malaria prevention, diagnosis and treatment and to healthcare services generally. This has already been recognised as a barrier to the utilization of formal heath care system. 34 PMDs and pharmacies were mostly used by community members for malaria treatment. These two drug retail outlets have already been identified as the main service providers for the treatment of malaria. 35 Unfortunately, some of these providers stock several anti-malarial drugs including those that are not recommended for treatment. 36 The result is their reliance on mono-therapies for the treatment of malaria. Several factors have been known to influence the choice of anti-malarial drugs by the PMDs and most important one is the personal choice of the vendor. 37 Other factors included influence by patients, representatives of drug companies and other providers working at the same facility or area. 38 The stocking of anti-malarial drugs by the providers may also have been influenced by cost as the retail drug outlets being privately owned may be concerned more on profit than national treatment guidelines. It has been established that ACTs are more expensive when compared with the mono-therapies. 35 This may influence the choice of anti-malarial use by the people in favour of monotherapies. This has already being identified as a challenge in the fight against malaria. 29 Even among the retail drug outlets, some differences exist. Based on Nigeria law, pharmacies should have the services of a trained pharmacist whose understanding of medicines and of health generally should be considerably higher than that of PMDs. Thus it has been found that poorer individuals seeking care at PMDs are more likely to receive inappropriate treatment when compared with those who go to pharmacies. 39 The reason why the pharmacies failed to dispense ACTs to clients remain unclear. With this evidence at hand, training of retail drug outlet operators on management of malaria is essential while also creating awareness among the populace on the new malaria treatment policy among the people. In effect, promoting affordable treatment for malaria is of prime importance, 26 and the drugs should be available always. 8 Hence there has been a call for the reduction of the cost of effective drugs for the treatment of malaria, in this case ACTs, and increasing its acceptability among the populace. 40 When compared with the PMDs and pharmacies, the public health facilities offer the highest quality of malaria treatment services to the people. 35 Based on this position, families are more satisfied with malaria treatment services from the public health facilities. The provision of quality assured treatment for all malaria patients has been identified as one of the strategies for the control of malaria. 29 This may explain why public health facilities are places of last resort when it becomes obvious that malaria treatment services from these retail drug outlets have failed or are about to fail. This notwithstanding, the experiences of the participants in these facilities have not been good. This has made it necessary to insist on the delivery of quality health services from public health facilities in Nigeria. Already there have been calls for the strengthening of the health systems in Nigeria, 34 as a way of ensuring quality health service delivery. 8 People in urban and rural areas seek for treatment of malaria in different treatment outlets with the rural dwellers preferring PMDs. 8, 41 The rural dwellers also prefer cheaper drugs, 41 and this may inform their reliance on herbal drugs for malaria treatment. These differences may be due to the gap between the people living in urban and rural areas of Nigeria when educational attainment and socio-economic status are considered.
2 For example in a study in a rural area in Nigeria a higher proportion of the respondents used herbal drugs to treat malaria when compared with those who used modern medicines. 42 
Conclusion
Community members preferred PMDs and pharmacies for malaria treatment. Unfortunately, these drug outlets do not encourage the use of ACT. This makes it necessary that pharmacists and PMDs are trained on management of malaria. Improving public knowledge on the need for malaria diagnosis before treatment and use of artemisinin-based combination therapy for treatment will improve the control of malaria. The populace should be instructed to seek treatment early while also discouraging the use of herbal drugs for malaria treatment. There is also the need to improve service delivery at public health facilities and introduce alternative financing mechanisms for healthcare thus reducing out of pocket expenditure for health by the people.
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